3rd Quarter - Report

ASCENSION HEALTH ALLIANCE D/B/A ASCENSION for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

Firm
Client
Income
—
Expenses
$840,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340B Program; Issues related to affordable prescription drugs; Issues related to health care workforce and staffing; Issues related to health care privacy; Issues related to telehealth authorities; Issues related to hospital price transparency; Issues related to hospital reimbursement; Issues related to nonprofit hospital practices; Issues related to hospital outpatient department payments; Issues related to hospital outpatient department payments; Medicaid Disproportionate Share Hospital payment adjustment program; Issues related to Medicare payments; Childrens Hospital Graduate Medical Education Program (CHGME); issues related to childrens medical care; Future Advancement of Academic Nursing (FAAN) Act; Veteran Nurses in Primary Care Program; H.R. 2584/S. 2768, the Safety From Violence for Healthcare Employees (SAVE) Act; Expanding Care in the Home Act; H.R. 1770, Equitable Access to Pharmacy Services Act; issues related to Program for All-Inclusive Care for the Elderly (PACE); H.R. 1770, Equitable Access to Pharmacy Services Act; H.R. 3008, the Drug Shortage Prevention Act; H.R. 3810, the Drug Origin Transparency Act; H.R. 3793, the Ensuring Access to Lifesaving Drugs Act; issues related to preventing and mitigating drug shortages; H.R. 2389/S. 1302, the Resident Physician Shortage Reduction Act; H.R. 3263, the Support Faculty and Expand Access to Nursing Act; issues related to prior authorization, unwarranted claim denials, and payment delays; S. 2840, the Bipartisan Primary Care and Health Workforce Expansion Act; the PATIENT Act

LobbyistCovered position, as disclosed
MARK HAYES 2004-2010:Health Policy Director & 2002-2004:Health Policy Advisor, Sen Finance Cmte; 2001-2002: Sr Health Policy Advsr, Sen. Snowe; 2001:Health Policy Advsr, Sen HELP Cmte; 94-95:Sr Advisor, Sen Sm Bus. Cmte; 94-99:LA 89-90:Staff Asst, Sen. Bond
PETER LEIBOLD —
JOSEPH LUSTIG New 2019-2020: Senior Policy Advisor, 2017-2019: Policy Advisor, 2015-2017: Legislative Assistant, 2014-2015: Legislative Correspondent, 2014: Staff Assistant, Rep. Cedric L. Richmond
DANIELLE WHITE 2010: Intern, Senate HELP Committee; 2005-2006: Scheduler, Rep. Nancy Johnson; 2004-2005: Staff Assistant, Rep. Nancy Johnson

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3263 (118th), S. 1302 (118th), H.R. 2389 (118th), H.R. 1770 (118th), H.R. 3810 (118th), S. 2768 (118th), S. 2840 (118th), H.R. 3008 (118th), H.R. 2584 (118th), H.R. 3793 (118th)

Medicare/Medicaid MMM

Issues related to affordable prescription drugs; Issues related to telehealth authorities; Issues related to health care workforce and staffing; Medicaid Disproportionate Share Hospital payment adjustment program; Issues related to Medicaid coverage; Issues related to hospital reimbursement; 340B Program; Issues related to hospital price transparency; Future Advancement of Academic Nursing (FAAN) Act; Expanding Care in the Home Act; H.R. 1770, Equitable Access to Pharmacy Services Act; issues related to Program for All-Inclusive Care for the Elderly (PACE); issues related to improving coordination of care for dual eligibles; issues related to site neutral payments; H.R. 3281, the Transparent PRICE Act; issues related to prior authorization, unwarranted claim denials, and payment delays, the Biologics Price Competition and Innovation Act (BPCIA); the PATIENT Act

LobbyistCovered position, as disclosed
MARK HAYES 2004-2010:Health Policy Director & 2002-2004:Health Policy Advisor, Sen Finance Cmte; 2001-2002: Sr Health Policy Advsr, Sen. Snowe; 2001:Health Policy Advsr, Sen HELP Cmte; 94-95:Sr Advisor, Sen Sm Bus. Cmte; 94-99:LA 89-90:Staff Asst, Sen. Bond
PETER LEIBOLD —
JOSEPH LUSTIG New 2019-2020: Senior Policy Advisor, 2017-2019: Policy Advisor, 2015-2017: Legislative Assistant, 2014-2015: Legislative Correspondent, 2014: Staff Assistant, Rep. Cedric L. Richmond
DANIELLE WHITE 2010: Intern, Senate HELP Committee; 2005-2006: Scheduler, Rep. Nancy Johnson; 2004-2005: Staff Assistant, Rep. Nancy Johnson

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1770 (118th), H.R. 3281 (118th)

Pharmacy PHA

340B Program; Issues related to affordable prescription drugs;H.R. 1770, Equitable Access to Pharmacy Services Act; H.R. 3008, the Drug Shortage Prevention Act; H.R. 3810, the Drug Origin Transparency Act; H.R. 3793, the Ensuring Access to Lifesaving Drugs Act; issues related to preventing and mitigating drug shortages;

LobbyistCovered position, as disclosed
MARK HAYES 2004-2010:Health Policy Director & 2002-2004:Health Policy Advisor, Sen Finance Cmte; 2001-2002: Sr Health Policy Advsr, Sen. Snowe; 2001:Health Policy Advsr, Sen HELP Cmte; 94-95:Sr Advisor, Sen Sm Bus. Cmte; 94-99:LA 89-90:Staff Asst, Sen. Bond
PETER LEIBOLD —
JOSEPH LUSTIG New 2019-2020: Senior Policy Advisor, 2017-2019: Policy Advisor, 2015-2017: Legislative Assistant, 2014-2015: Legislative Correspondent, 2014: Staff Assistant, Rep. Cedric L. Richmond
DANIELLE WHITE 2010: Intern, Senate HELP Committee; 2005-2006: Scheduler, Rep. Nancy Johnson; 2004-2005: Staff Assistant, Rep. Nancy Johnson

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA)

Bills named: H.R. 3008 (118th), H.R. 3810 (118th), H.R. 1770 (118th), H.R. 3793 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.